发明名称 |
Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition |
摘要 |
The invention relates to a group of novel phenylpiperazine derivatives with a dual mode of action: serotonin reuptake inhibition and partial agonism on dopamine-D<SUB>2 </SUB>receptors. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect. The compounds have the general formula (1): wherein the symbols have the meanings given in the specification. and tautomers, stereoisomers and N-oxides thereof, as well as pharmacologically acceptable salts, hydrates and solvates of said compounds of formula (1) and its tautomers, stereoisomers and N-oxides.
|
申请公布号 |
US2006122189(A1) |
申请公布日期 |
2006.06.08 |
申请号 |
US20050294602 |
申请日期 |
2005.12.06 |
申请人 |
SOLVAY PHARMACEUTICALS B.V. |
发明人 |
FEENSTRA ROELOF W.;STOIT AXEL;TERPSTRA JAN-WILLEM;PRAS-RAVES MARIA L.;MCCREARY ANDREW C.;VAN VLIET BERNARD J.;HESSELINK MAYKE B.;KRUSE CORNELIS G.;VAN SCHARRENBURG GUSTAAF J. |
分类号 |
A61K31/496;C07D413/02;C07D413/14 |
主分类号 |
A61K31/496 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|